QELBREE 150 mg/1

QELBREE 150 mg is an extended-release capsule containing viloxazine hydrochloride, used for managing certain mental health conditions. This medication is designed to provide sustained relief and is manufactured by Supernus Pharmaceuticals, Inc.

QELBREE 150 mg is primarily used for the management of specific mental health conditions. Viloxazine hydrochloride, the active ingredient, is often prescribed to help alleviate symptoms associated with these conditions. The extended-release formulation ensures a steady release of the medication over time, which may help maintain consistent levels in the body.

Common effects of QELBREE 150 mg may include changes in mood, appetite, or sleep patterns. Some individuals might experience mild gastrointestinal discomfort or fatigue. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

QELBREE 150 mg should be handled with care and stored as directed. It is important to follow the guidance of a healthcare provider regarding its use. This medication may not be suitable for everyone, especially those with certain pre-existing conditions or allergies. Always consult a healthcare professional before starting any new medication.

QELBREE 150 mg may interact with other medications, including those that affect the central nervous system. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol and certain supplements may also interact with viloxazine hydrochloride, so it is important to discuss these with a healthcare professional.